Clinical Study

Intravenous Methadone for Severe Cancer Pain: A Presentation of 10 Cases

Table 1

Patient’s characteristics.

PatientsSexAgeType of cancerPain treatment (mg/day)

1F32Vulvar sarcomaHydromorphone 300/ketamine 150 (i.v.)
2F48Lung (SCLC)Oral methadone 210
3M49RectumOral methadone 180
4F20Ewing sarcomaOral methadone 240
5M49ColonMorphine 900 (i.v.)
6F60Vulvar carcinomaOral methadone 240
7F64Vulvar carcinomaHydromorphone 50 (i.v.)
8F37Vaginal carcinomaOral methadone 45
9F55Uterine carcinomaFentanyl 300 ( g/H)
10M41Pelvic angiosarcomaHydromorphone 130/ketamine 100